Harrow (HROW) Non-Current Debt (2011 - 2026)
Harrow (HROW) posted quarterly Non-Current Debt of $292.1 million for Q1 2026, up 159.63% year-over-year from $112.5 million in Q1 2025, and up 20.11% quarter-over-quarter from $243.2 million in Q4 2025.
Harrow (HROW) Non-Current Debt (2011 - 2026) Analysis & Trends
Harrow's Non-Current Debt history runs 13 years deep, the most recent figure standing at $292.1 million for Q1 2026.
- In Q1 2026, Non-Current Debt rose 159.63% year-over-year to $292.1 million; the TTM figure through Mar 2026 stood at $292.1 million (up 159.63% YoY), while the FY2025 annual figure was $243.2 million, up 10.77% from the prior year.
- Non-Current Debt for Q1 2026 stood at $292.1 million, up from $243.2 million in the prior quarter.
- The five-year high for Non-Current Debt was $292.1 million in Q1 2026, with the low at $38.5 million in Q2 2025.
- The 5-year median for Non-Current Debt is $182.2 million (2023), against an average of $160.6 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt surged 553.39% in 2022, then sank 79.2% in 2025.
- Harrow's Non-Current Debt stood at $104.2 million in 2022, then soared by 78.44% to $185.9 million in 2023, then grew by 18.1% to $219.5 million in 2024, then rose by 10.77% to $243.2 million in 2025, then increased by 20.11% to $292.1 million in 2026.
- Business Quant data shows HROW's Non-Current Debt at $292.1 million in Q1 2026, $243.2 million in Q4 2025, and $242.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 130.00 Mn |
| 10 | Harrow | 1.59 Bn | 1.51 Bn | 50.36 Mn | 292.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 292.38 Mn |
| Mar 31, 2026 | 292.09 Mn |
| Dec 31, 2025 | 243.18 Mn |
| Sep 30, 2025 | 242.87 Mn |
| Jun 30, 2025 | 38.48 Mn |
| Mar 31, 2025 | 112.50 Mn |
| Dec 31, 2024 | 219.54 Mn |
| Sep 30, 2024 | 186.06 Mn |
| Jun 30, 2024 | 185.02 Mn |
| Mar 31, 2024 | 184.15 Mn |
| Dec 31, 2023 | 185.89 Mn |
| Sep 30, 2023 | 182.19 Mn |
| Jun 30, 2023 | 169.71 Mn |
| Mar 31, 2023 | 168.85 Mn |
| Dec 31, 2022 | 104.17 Mn |
| Sep 30, 2022 | 72.24 Mn |
| Jun 30, 2022 | 72.04 Mn |
| Mar 31, 2022 | 71.85 Mn |
| Dec 31, 2021 | 71.65 Mn |
| Sep 30, 2021 | 71.46 Mn |